Erratum: Once-Daily Prolonged-Release Tacrolimus (ADVAGRAF) Versus Twice-Daily Tacrolimus (PROGRAF) in Liver Transplantation (American Journal of Transplantation (2010) 10:10 (2313-2323) DOI: 10.1111/j.1600-6143.2010.03255.x);Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation

American Journal of Transplantation

Volumn 10, Issue 10, 2010, Pages 2313-2323

  Trunecka P ^a   Boillot, O ^b   Seehofer, D ^c   Pinna, A D ^d   Fischer, L ^e   Ericzon, B G ^f   Troisi, R I ^g   Baccarani, U ^h   Ortiz De Urbina, J ⁱ   Wall, W ^j  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c Klinik Transplantationschirurgie   (Germany)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

^h UNIVERSITY OF UDINE   (Italy)

ⁱ Unidad de Trasplante Hepatico   (Spain)

^j LONDON HEALTH SCIENCES CENTRE   (Canada)

more..

Author keywords

Hepatic transplantation; immunosuppression; phase III; randomized controlled trial; tacrolimus

Indexed keywords

METHYLPREDNISOLONE; PLACEBO; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 77957205275     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03347.x     Document Type: Erratum

References (25)

1. Morrissey PE, Flynn ML, Lin S. Medication noncompliance and its implications in transplant recipients. Drugs 2007 67: 1463 1481. (Pubitemid 47026394)
2. Weng FL, Israni AK, Joffe MM et al. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol 2005 16: 1839 1848.
3. O'Carroll R, McGregor LM, Swanson V, Masterton G, Hayes P. Adherence to medication after liver transplantation in Scotland: A pilot study. Liver Transplant 2006 12: 1862 1868. (Pubitemid 44911813)
4. Butler J, Roderick P, Mullee M, Mason J, Peveler R. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review. Transplantation 2004 77: 769 776. (Pubitemid 38366989)
5. Vasquez EM, Tanzi M, Benedetti E, Pollak R. Medication noncompliance after kidney transplantation. Am J Health-Syst Pharm 2003 60: 266 269. (Pubitemid 36749051)
6. Chisholm M, Mulloy L, DiPiro J. Comparing renal transplant patients' adherence to free cyclosporine and free tacrolimus immunosuppressant therapy. Clin Transplant 2005 19: 77 82. (Pubitemid 40227856)
7. Florman S, Alloway R, Kalayoglu M et al. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. Transplant Proc 2005 37: 1211 1213. (Pubitemid 40590839)
8. Berlakovich G, Langer F, Freundorfer E et al. General compliance after liver transplantation for alcoholic cirrhosis. Transpl Int 2000 13: 129 135. (Pubitemid 30417368)
9. Gaston RS, Hudson SL, Ward M, Jones P, Macon R. Late renal allograft loss: Noncompliance masquerading as chronic rejection. Transplant Proc 1999 31 (Suppl 4A 21S 23S. (Pubitemid 29282400)
10. Denhaerynck K, Dobbels F, Cleemput I et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: A literature review. Transpl Int 2005 18: 1121 1133. (Pubitemid 41726755)
11. Undre NA. Use of a once-daily modified release tacrolimus regimen in de novo liver transplant recipients [abstract 859]. Am J Transplant 2005 5 (Suppl 11 374.
12. Demetris A, Batts K, Dhillon A et al. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997 25: 658 663. (Pubitemid 27106450)
13. Mulbacher F. Tacrolimus versus cyclosporin microemulsion in liver transplantation: Results of a 3-month study. Transplant Proc 2001 33: 1339 1340.
14. McAlister V, Haddad E, Renof E, Malthaner R, Kjaer M, Gluud L. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: A meta-analysis. Am J Trans 2006 6: 1578 1585. (Pubitemid 43945797)
15. Burroughs A, Sabin C, Rolles K et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: Predictive models for outcome. Lancet 2006 367: 225 232. (Pubitemid 43107667)
16. Becker T, Foltys D, Bilbao I et al. Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation 2008 86: 1689 1694.
17. Boillot O, Mayer D, Boudjema K et al. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: A large randomized clinical study. Liver Transpl 2005 11: 61 67. (Pubitemid 40124443)
18. Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus: A further update of its use in the management of organ transplantation. Drugs 2003 63: 1247 1297. (Pubitemid 36750952)
19. Lucey M, Abdelmalek M, Gagliardi R et al. A comparison of tacrolimus and cyclosporine in liver transplantation: Effects on renal function and cardiovascular risk status. Am J Transplant 2005 5: 1111 1119. (Pubitemid 40571262)
20. Ojo A, Held P, Port F et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003 349: 931 940. (Pubitemid 37064766)
21. Wilkinson A, Pham P-T. Kidney dysfunction in the recipients of liver transplants. Liver Transpl 2005 11: S47 S51. (Pubitemid 43072615)
22. Nankivell B, Chapman J, Bonovas G, Gruenewald S. Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. Transplantation 2005 77: 1457 1459. (Pubitemid 38668444)
23. van Hooff JP, Gelens M, Boots JM, van Duijnhoven EM, Dackus J, Christiaans MH. Preservation of renal function and cardiovascular risk factors. Transplant Proc 2006 38: 1987 1991. (Pubitemid 46068495)
24. Klein I, Abrahams A, van Ede T, Hené R, Koomans H, Lightenberg G. Different effects of tacrolimus and cyclosporine in renal hemodynamics and blood pressure in healthy subjects. Transplantation 2002 73: 732 736. (Pubitemid 34260568)
25. Trunecka P, Boillot O, Langrehr J et al. Tacrolimus once-daily prolonged release versus tacrolimus twice-daily in combination with steroids - a phase III multicentre liver study [abstract]. Transplantation 2008 86 (Suppl 2 301.